CD4 and neoplasm: Collectively, oxaliplatin depleted Mo‐MDSCs and PMN‐MDSCs in tumor‐bearing mice, analogously to gemcitabine, but it did not significantly affect levels of effector CD4+/CD8+ T cells or Tregs.